European Medicines Agency (EMA) and European Alliance of Associations for Rheumatology (EULAR) bilateral meeting

EventHuman

Slovak is available via eTranslation, the European Commission's machine translation service.

Translate to Slovak | Important information about machine translation

Date

, -

Miesto

Online
European Medicines Agency, Amsterdam, the Netherlands

Event summary

The purpose of this bilateral meeting is to exchange information through interactive discussions and to explore mutual areas of interest and potential collaboration formats. 

Topics include:

  • rheumatic and musculoskeletal diseases (RMDs) in Europe,
  • activities of the Rheumatology/Immunology Working Party,
  • Clinical Trials Transformation,
  • ACT EU initiatives 

EULAR is also to present its initiative, the EULAR Network of Trial Centers (ENTRI).

Documents

Agenda - European Medicines Agency (EMA) - European Alliance of Associations for Rheumatology (EULAR) bilateral meeting - March 2026

Draft Reference Number: EMA/13450/2026

English (EN) (93.62 KB - PDF)

Prvýkrát uverejnené:
Zobraziť

Highlights - EMA - European Alliance of Associations for Rheumatology (EULAR) bilateral meeting - March 2026

Reference Number: EMA/73196/2026

English (EN) (123.12 KB - PDF)

Prvýkrát uverejnené:
Zobraziť

Share this page